Diabetes Mellitus Type 2 (T2DM)
8
3
4
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
25.0%
2 terminated out of 8 trials
50.0%
-36.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice Cream
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
Increasing CGM Use Among Patients With T2D
Efect Supplementation Vitamin D in Diabetes Mellitus Type 2
Relationship Between Hemodynamic Changes and Cardiopulmonary Fitness in Type 2 Diabetes Mellitus Patients
Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes
Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus
Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus